Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.470
-0.050 (-3.29%)
At close: Mar 27, 2026, 4:00 PM EDT
1.410
-0.060 (-4.08%)
After-hours: Mar 27, 2026, 4:31 PM EDT

Arcadia Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4.865.054.457.426.78
Revenue Growth (YoY)
-3.71%13.27%-39.96%9.41%-15.61%
Cost of Revenue
3.12.962.176.18.71
Gross Profit
1.762.082.281.32-1.93
Selling, General & Admin
79.648.2315.0422.94
Research & Development
0.010.050.061.513.89
Other Operating Expenses
-2.75-3.960.08-1.226.77
Total Operating Expenses
4.265.738.3815.3233.6
Operating Income
-2.5-3.65-6.1-14.01-35.53
Interest Income
0.220.780.70.29-
Interest Expense
-----0.02
Other Non-Operating Income (Expense)
-0.05-1.440.092.919.41
Total Non-Operating Income (Expense)
0.17-0.660.783.1919.39
Pretax Income
-2.33-4.31-5.32-10.81-16.13
Provision for Income Taxes
0.010.010.010.010
Net Income
-2.34-7.04-13.98-15.38-14.66
Minority Interest in Earnings
--0.010.241.47
Earnings From Discontinued Operations
--2.72-8.66-4.78-
Net Income to Common
-2.34-7.04-13.98-15.38-14.66
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
Shares Change (YoY)
0.35%10.22%106.37%12.66%113.68%
EPS (Basic)
-1.71-5.17-4.30-17.67-27.56
EPS (Diluted)
-1.71-5.17-4.30-17.67-27.56
Free Cash Flow
-4.74-9.64-15.3-14.05-26.88
Free Cash Flow Per Share
-3.46-7.07-12.37-23.44-50.52
Gross Margin
36.23%41.27%51.19%17.75%-28.44%
Operating Margin
-51.46%-72.31%-137.00%-188.82%-523.98%
Profit Margin
-48.15%-85.57%-314.01%-210.46%-237.96%
FCF Margin
-97.55%-191.14%-343.49%-189.39%-396.39%
EBITDA
-2.35-2.88-5.12-12.64-33.21
EBITDA Margin
-48.29%-57.15%-114.91%-170.45%-489.75%
EBIT
-2.5-3.65-6.1-14.01-35.53
EBIT Margin
-51.46%-72.31%-137.00%-188.82%-523.98%
Effective Tax Rate
-0.34%-0.19%-0.15%-0.13%-0.01%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q